Comerica Bank
ARCT icon

Comerica Bank’s Arcturus Therapeutics ARCT Stock Holding History

Comerica Bank’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-78
Closed -$1.81K – 3685
2024
Q3 		$1.81K Sell
78
-55
-41% -$1.18K ﹤0.01% 3513
2024
Q2 		$3.24K Sell
133
-720
-84% -$21.8K ﹤0.01% 3382
2024
Q1 		$28.8K Buy
853
+149
+21% +$5.28K ﹤0.01% 2927
2023
Q4 		$22.2K Buy
704
+625
+791% +$14.9K ﹤0.01% 2944
2023
Q3 		$2.02K Buy
+79
New +$2.43K ﹤0.01% 3569

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Comerica Bank's ARCT Position: Q4 2024 in Review

Comerica Bank sold out of Arcturus Therapeutics (ARCT) in Q4 2024, closing a stake of 78 shares — an estimated $1.81K sold.

Comerica Bank first reported a position in ARCT in Q3 2023 and held it in 5 quarters. The position peaked at $28.8K in Q1 2024. 147 funds tracked by Wall St. Rank hold ARCT as of Q4 2024.

  • Comerica Bank reported no remaining Arcturus Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Comerica Bank sold 78 Arcturus Therapeutics shares in Q4 2024, an estimated $1.81K.
  • Comerica Bank first reported a position in Arcturus Therapeutics in Q3 2023 and held it in 5 quarters.
  • Comerica Bank's Arcturus Therapeutics position peaked at $28.8K in Q1 2024.
  • 147 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2024.

Based on Comerica Bank's 13F filing for Q4 2024, filed 14 Feb 2025.